Investor FAQs

 

Epizyme was incorporated in the state of Delaware on November 1, 2007.

Epizyme’s headquarters are located at 400 Technology Square, 4th Floor, Cambridge, Mass., U.S. The main office phone number is (617) 229-5872.

Epizyme’s stock is traded on the NASDAQ Global Market under the symbol EPZM. The company’s initial public offering (IPO) was on May 30, 2013.

The CUSIP number for Epizyme’s common stock is 29428V 104.

Shares can be purchased through a stockbroker of your choice. Epizyme does not have a direct stock purchase plan.

We do not currently offer a dividend reinvestment program. We intend to retain all future earnings to finance the growth and development of our business and do not anticipate paying any cash dividends to our stockholders in the foreseeable future.

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone:  +1 800 962 4284
International Phone:  +1 781 575 3120

If you have misplaced your stock certificates, please contact Epizyme’s transfer agent, Computershare (contact information provided above). There may be a fee involved for replacing lost stock certificates.

If your shares are held in your name, you must contact our transfer agent, Computershare. If your shares are held in street name, you must contact your broker to update your address.

Our legal counsel is:
Wilmer Cutler Pickering Hale and Dorr LLP
60 State Street
Boston, MA 02109 USA
+1 617 526 6000 (t)

Our independent auditor is:
Ernst & Young LLP
200 Clarendon Street
Boston, MA 02116
+1 617 266 2000 (t)

Please go to the Shareholder Tools section on the left side of this page and click on the Download Library link. To receive printed materials by postal mail, click on the Printed Materials icon in this section.

Please submit your question using the form below.

Contact Form
* Indicates required field
http://apps.shareholder.com/captcha/captcha.aspx?verifyid=1804568225&CompanyID=AMDA-1RBIC2&t=.jpg